On January 4, 2024, The Innovation announced the Top Ten Global Science and Technology Innovation Foci in 2023. Among them, OvaRePred, the first global non-invasive assessment and prediction tool for ovarian reserve, was independently developed by the Department of Reproductive Medicine, Peking University Third Hospital.

　　Using advanced algorithms and big data, OvaRePred can not only evaluate women’s current ovarian reserve, but also predict the age of key fertility milestones such as decreased ovarian reserve (DOR) and perimenopausal period, so that women can individualize their own fertility plan and perimenopausal health management.

　　OvaRePred has been routinely used in many hospitals and physical examination centers in China. With the expansion of its application, OvaRePred is expected to deepen the understanding of female fertility and perimenopausal period in the whole society, so as to improve the efficiency of women’s health management worldwide. OvaRePred not only represents a major advance in medical technology, but also ushers in a new era of precision reproductive health management.

　　The Innovation is a comprehensive English academic journal co-founded by young scientists and Cell Press in 2020. It publishes the annual top ten scientific and technological innovation foci every year, and has accurately predicted the trend of global science and technology development.

　　Written by: Lang Lang

　　Edited by: Liu Xin

　　Source: PKUTH